ask="1.22"
ask_size="300"
average_daily_volume="334600"
bid="1.18"
bid_size="600"
book_value="1.98"
change="-2.86"
change_from_200_day_moving_average="-3.08"
change_from_50_day_moving_average="-2.75"
change_from_52_week_high="-6.97"
change_From_52_week_low="0.10"
change_in_percent="-70.79%"
close="1.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="1.30"
high_52_weeks="8.15"
last_trade_date="2/1/2017"
last_trade_price="1.18"
last_trade_size="21451"
last_trade_time="4:00pm"
low="1.08"
low_52_weeks="1.08"
market_capitalization="22.01M"
moving_average_200_day="4.26"
moving_average_50_day="3.93"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="1.28"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-72.30%"
percent_change_from_50_day_moving_average="-70.01%"
percent_change_from_52_week_high="-85.52%"
percent_change_from_52_week_low="+9.26%"
previous_close="4.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.04"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="1.69"
stock_exchange="NGM"
symbol="CATB"
volume="7640980"
weeks_range_52="1.08 - 8.15"
